You are here

  • Home
  • Archive
  • Volume 15, Issue 2
  • Over 12 months, an immunisation navigator programme for urban adolescents increased immunisation rates by approximately 13% compared with control

Article Text

Article menu
Download PDFPDF
Child health
Randomised controlled trial
Over 12 months, an immunisation navigator programme for urban adolescents increased immunisation rates by approximately 13% compared with control
  1. Regena Spratling
  1. Department of Nursing, North Georgia College and State University, Dahlonega, Georgia, USA
  1. Correspondence to Regena Spratling
    Department of Nursing, North Georgia College and State University, Health & Natural Sciences Building, Dahlonega, Georgia 30597, USA; rgspratling{at}northgeorgia.edu

https://doi.org/10.1136/ebn.2011.100220

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Szilagyi PG, Humiston SG, Gallivan S, et al. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med 2011;165:547–53.OpenUrlCrossRefPubMed

    Implications for Nursing Practice and Research

    • ■ Interventions that include patient tracking, reminder/recall and home visits can improve adolescent immunisation rates and preventive care visit rates.

    • ■ Implementation of interventions aimed at immunisations and preventive care are needed to enhance adolescent care.

    • ■ Research in development and implementation of programmes on a local, regional and national level are needed to address adolescent immunisation rates and preventive care.

    Context

    Interventions that increase adolescent immunisation rates and preventive care visits are needed. This is demonstrated by data relating to vaccination coverage in the USA for the meningococcus (62.7%), pertussis vaccine (68.7%) and papilloma virus (32%; three …

    View Full Text

    Footnotes

    • Competing interests None.